| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = -$541 ) |
| | 2025 | 2022 | AFFIRMED PHARMA LLC | 10709 EHLERS RD | CONROE | TX | 77302-4025 | MONTGOMERY | USA | R41EY033583 | Rusalatide Acetate (TP508) Mitigation of Genotoxic Radiation Damage in Human Lens Epithelial Cells | 000 | 1 | NIH | 3/17/2025 | -$456 |
| | 2025 | 2022 | AFFIRMED PHARMA LLC | 10709 EHLERS RD | CONROE | TX | 77302-4025 | MONTGOMERY | USA | R41EY033583 | Rusalatide Acetate (TP508) Mitigation of Genotoxic Radiation Damage in Human Lens Epithelial Cells | 001 | 1 | NIH | 3/17/2025 | -$85 |
|
| Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2023 | AFFIRMED PHARMA LLC | 10709 EHLERS RD | CONROE | TX | 77302-4025 | MONTGOMERY | USA | R41EY034773 | Rusalatide Acetate (TP508) Mitigation Effect on Radiation Induced Keratopathy | 001 | 1 | NIH | 1/23/2024 | $0 |
| | 2024 | 2023 | AFFIRMED PHARMA, LLC | 10709 EHLERS RD | CONROE | TX | 77302-4025 | MONTGOMERY | USA | R41EY034773 | Rusalatide Acetate (TP508) Mitigation Effect on Radiation Induced Keratopathy | 000 | 1 | NIH | 10/16/2023 | $0 |
| | 2024 | 2022 | AFFIRMED PHARMA LLC | 10709 EHLERS RD | CONROE | TX | 77302-4025 | MONTGOMERY | USA | R41EY033583 | Rusalatide Acetate (TP508) Mitigation of Genotoxic Radiation Damage in Human Lens Epithelial Cells | 000 | 1 | NIH | 1/23/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $341,302 ) |
| | 2023 | 2023 | AFFIRMED PHARMA, LLC | 10709 EHLERS RD | CONROE | TX | 77302-4025 | MONTGOMERY | USA | R41EY034773 | Rusalatide Acetate (TP508) Mitigation Effect on Radiation Induced Keratopathy | 000 | 1 | NIH | 9/15/2023 | $341,302 |
| | 2023 | 2022 | AFFIRMED PHARMA, LLC | 10709 EHLERS RD | CONROE | TX | 77302-4025 | MONTGOMERY | USA | R41EY033583 | Rusalatide Acetate (TP508) Mitigation of Genotoxic Radiation Damage in Human Lens Epithelial Cells | 000 | 1 | NIH | 5/8/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $388,773 ) |
| | 2022 | 2022 | AFFIRMED PHARMA, LLC | 10709 EHLERS RD | CONROE | TX | 77302-4025 | MONTGOMERY | USA | R41EY033583 | Rusalatide Acetate (TP508) Mitigation of Genotoxic Radiation Damage in Human Lens Epithelial Cells | 000 | 1 | NIH | 1/13/2022 | $327,510 |
| | 2022 | 2022 | AFFIRMED PHARMA, LLC | 10709 EHLERS RD | CONROE | TX | 77302-4025 | MONTGOMERY | USA | R41EY033583 | Rusalatide Acetate (TP508) Mitigation of Genotoxic Radiation Damage in Human Lens Epithelial Cells | 001 | 1 | NIH | 9/20/2022 | $61,263 |
|
|
